This INNOVO Open Call is part of Novo Nordisk 2023 partner
campaign. The proposals will be submitted to the global platform.
The application journey
We encourage applicants to submit their proposals as soon as
possible, since applications will be evaluated on a rolling basis.
We aim to make the application/evaluation process as straightforward
and quick as possible (<1 month). No lengthy proposals are
required, 1-2 pages describing the idea and the experimental plan for
validation are sufficient.
A panel of Novo Nordisk experts will review applications and make
the decision on a potential funding/partnership opportunity.
Evaluation criteria include scientific novelty, potential therapeutic
impact and robustness of experimental plan (“killer experiments”).
Applicants may be invited to present/discuss their proposal if
further clarification is needed.
We will execute a standard statement of work/research collaboration
agreement. Again, IP rights stay with you/your organisation and you
are free to publish.
4. Let’s go!
If your proposal is approved, Novo Nordisk will fund key experiments
performed in your laboratory to validate your translational idea.
During the process, Novo Nordisk experts will be available for
feedback and advice, and you will have access to Novo Nordisk open
After 6-9 months of hard work, you will present your results to Novo
Nordisk experts and receive feedback. If both parties interested, we
would love to discuss follow-up funding and long-term partnership options.
About INNOVO® Open Call
Download invitation letter
More questions? Pls contact us via firstname.lastname@example.org